
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be made contingent upon participation in such services, the Food and Drug Administration and Substance Abuse and Mental Health Services Administration told health care providers in guidance intended to clarify buprenorphine prescribing recommendations.